Stanley Laman Group, Ltd. Bristol Myers Squibb CO Transaction History

Stanley Laman Group, Ltd.

$529 Million
Q1 2025

A detailed history of Stanley Laman Group, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 4,500 shares of BMY stock, worth $215,415. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,500

Previous 4,500 -0.0%

Holding current value

$215,415

Previous $254,000 7.87%

% of portfolio

0.05%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $178,866 - $233,392	-4,510 Reduced 50.06%	4,500 $232,000
Q2 2024 Jul 18, 2024	BUY	$40.25 - $52.99 $107,467 - $141,483	2,670 Added 42.11%	9,010 $374,000
Q1 2024 Apr 17, 2024	BUY	$47.98 - $54.4 $11,899 - $13,491	248 Added 4.07%	6,340 $343,000
Q4 2023 Feb 02, 2024	BUY	$48.48 - $57.85 $15,125 - $18,049	312 Added 5.4%	6,092 $312,000
Q3 2023 Oct 16, 2023	SELL	$57.89 - $64.73 $57,890 - $64,730	-1,000 Reduced 14.75%	5,780 $335,000
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $64,155 - $71,235	1,007 Added 17.44%	6,780 $433,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $379,343 - $430,261	5,773 New	5,773 $400,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $386,193 - $425,333	5,318 New	5,318 $409,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $1.55 Million - $1.69 Million	-25,069 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $217,718 - $244,869	-3,669 Reduced 12.77%	25,069 $1.58 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $250,533 - $283,900	4,339 Added 17.78%	28,738 $1.78 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $49,504 - $54,857	-862 Reduced 3.41%	24,399 $1.47 Million
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $93,413 - $109,209	1,704 Added 7.23%	25,261 $1.49 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $41,388 - $60,147	-892 Reduced 3.65%	23,557 $1.31 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $886,173 - $1.16 Million	18,008 Added 279.58%	24,449 $1.57 Million
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $249,291 - $275,662	-5,587 Reduced 46.45%	6,441 $292,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $542,703 - $647,106	12,028 New	12,028 $574,000

Others Institutions Holding BMY

# of Institutions

2,805

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $102B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Bristol Myers Squibb CO Transaction History